BMJ - Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial

BMJ - Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial

https://www.bmj.com/content/372/bmj.n84  

9 de fevereiro de 2021

Categorias

Categorias

Arquivo de Notícias

Arquivo